THE NEW POSSIBLE
November 14 – 15, 2018 • Harvard Medical School, Boston, MA
The 14th Annual Personalized Medicine Conference was organized by a cross-industry, cross-disciplinary panel, made up of 29 providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.
EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition
Amy Abernethy, M.D., Ph.D.
Chief Medical Officer, Chief Scientific Officer, Senior Vice President, Oncology, Flatiron Health
Bonnie J. Addario
Founder, Chair, Bonnie J. Addario Lung Cancer Foundation; lung cancer survivor
Steven D. Averbuch, M.D.
Vice President, Head, Precision Medicine Research & Development, Bristol-Myers Squibb
Director, Alliance Development, Biotechnology Innovation Organization
Alex J. Carlisle, Ph.D.
Chairman, CEO, National Alliance Against Disparities in Patient Health
Donna R. Cryer, J.D.
President, CEO, Global Liver Institute
William S. Dalton, Ph.D., M.D.
Founder, Executive Chairman, M2Gen; Director, DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center
Kevin Davies, Ph.D.
Executive Editor, The CRISPR Journal
Stephen L. Eck, M.D., Ph.D.
President, CEO, Aravive Biologics
Robert C. Green, M.D., M.P.H.
Director of the Genomes2People Research Program, Professor of Medicine (Genetics), Brigham and Women’s Hospital, Broad Institute and Harvard Medical School
Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator
Dan Leonard, M.A.
President, National Pharmaceutical Council
Founder, Publisher, Genome magazine
Founder, Managing Partner, GreyBird Ventures LLC
Cynthia Morton, Ph.D.
William Lambert Professor of Obstetrics, Gynecology and Reproductive Biology, Professor of Pathology, Harvard Medical School; Director of Cytogenetics, Brigham and Women’s Hospital
Sukumar Nagendran, M.D.
Senior Vice President, Chief Medical Officer, AveXis
Lincoln Nadauld, M.D., Ph.D.
Executive Director, Precision Medicine and Precision Genomics, Intermountain Healthcare
Michael J. Pellini, M.D.
Managing Partner, Section 32
Chairman of the Board, CEO, President, Genomic Health
Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Enterprise Scientific Technology Operations, Worldwide Research & Development, Pfizer
Michael Sherman, M.D.
Senior Vice President, Chief Medical Officer, Harvard Pilgrim Health Care
Ralph Snyderman, M.D.
James B. Duke Professor of Medicine, Duke University
Executive Vice President, Chief Operating Officer, Thermo Fisher Scientific
Global Head of Life Sciences Strategy, EY Parthenon
Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting
Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Quest Diagnostics
Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Precision Medicine, Novartis